期刊文献+

TNF-αsICAM-1BNP在扩张型心肌病及缺血性心肌病中的不同变化和临床意义 被引量:3

The diversification and clinical significance of TNF-α, sICAM-1 and BNP in DCM and ICM
原文传递
导出
摘要 目的研究肿瘤坏死因子-α(TNF-α)、可溶性细胞间粘附因子-1(sICAM-1)及脑钠肽(BNP)在扩张型心肌病(DCM)和缺血性心肌病(ICM)中的不同变化,并探讨其临床意义。方法对76名DCM和64名ICM患者进行心功能分级并检测血清中TNF-α、sICAM-1及BNP浓度,组内和组间进行比较。结果TNF-α、sICAM-1和BNP在两组间均随着心功能恶化而升高(P〈0.01)。在相同心功能间,TNF-α,sICAM-1在DCM组明显高于ICM组(P〈0.01),而BNP则变化不显著(P〉0.05)。结论DCM患者始终存在着免疫损伤和炎症,检测TNF-α、sICAM-1对DCM及ICM鉴别诊断有临床意义。BNP是反映心功能不全的指标,对二者的鉴别诊断意义不大。 Objective To study the diversification of TNF-α, sICAM-1 and BNP in DCM and ICM, and to discuss the chinical significance of than. Methods 76 patients were DCM group and 64 patients were ICM group. We graded the 140 patients according to the NYHA classification and detected concentrations of TNF-α, sICAM-1 and BNP in patients' serum, then we compared the data within and between the two groups. Results The higher the NYHA classification of the patients, the higher the concentrations of TNF-α, sICAM-1 and BNP in both groups( P 〈 0.01 ). Among the patients with the same NYHA classification, the concentrations of TNF-α, sICAM-1 in DCM group is significantly higher than those in ICM group(P 〈0.01 ) ,while the diversifications of BNP concentration in the two groups were not observable (P 〉 0. 05 ). Conclusions As the immune injure and inflammation is always existed in DCM patients, to detect the concentrations of TNF-α, sICAM-1 has chinical significance for us to distinguish DCM from ICM. But for BNP, as it is one of the indexes of heart failure, there is almost no chinical significance.
出处 《中国临床实用医学》 2010年第2期46-48,共3页 China Clinical Practical Medicine
关键词 肿瘤坏死因子-α 可溶性细胞间粘附因子-1 脑钠肽 扩张型心肌病 缺血性心肌病 Tumor necrosis factor-alpla(TNF-α) Intercellular adhesion molecule-1 Brain natriuretic peptide(BNP) Dilated cardiomyopathy Schemic cardiomyopathy
  • 相关文献

参考文献4

二级参考文献9

  • 1马宾,牛小麟,王明霞,任付先.参麦注射液对扩张型心肌病患者免疫功能的影响[J].中国中西医结合杂志,2005,25(4):320-323. 被引量:20
  • 2Knoll RH,Hoshijima M,Chien KR.Mechanism of dilated cardiomyopathies.Drug Discovery Today:Disease Mechanism? Cardiovascular diseases,2004,1:31-36.
  • 3Erilksson U,Penninger JM,Kopf M.Mechanisms of autoimmune heart disease.Drug Discovery Today:Disease Mechanism? Cardiovascular diseases,2004,1:283-288.
  • 4Olson TM,Michels VV,Ballew JD,et al.Sodium channel mutation and susceptibility to heart failure and atrial fibrillation.JAMA,2005,293:447-454.
  • 5Akar FG,Tomaselli GF.Conduction abnormalities in nonischemic dilated cardiomyopathy:basic mechanisms and arrhythmic consequences.TCM,2005,15:259-264.
  • 6Lorenzen-Schmidt A,Stuyvers BD,Keurs HEDJ,et al.Young MLP deficient mice show diastolic dysfunction before the onset of dilated cardiomyopathy.JMCC,2005,39:241-250.
  • 7A. Stolpe,P. T. Saag. Intercellular adhesion molecule-1[J] 1996,Journal of Molecular Medicine(1):13~33
  • 8沈茜,徐玉莲,凌伟,吴泓.柯萨基B3病毒感染增强单个核细胞与心脏微血管内皮细胞的粘附[J].中国免疫学杂志,1999,15(7):302-304. 被引量:8
  • 9马宾,王明霞,任付先,欧研,牛小麟.扩张型心肌病红细胞免疫功能及其与硒的关系[J].世界核心医学期刊文摘(眼科学分册),2004(6):1394-1396. 被引量:3

共引文献100

同被引文献43

  • 1宋治远.缺血性心肌病的诊断和鉴别诊断[J].中国医师进修杂志(内科版),2006,29(10):1-3. 被引量:11
  • 2李利强,张瑞红,吴慧敏.扩张型心肌病患者血清TNF—α浓度与左室舒张末期容积的相关性研究[J].实用医技杂志,2007,14(21):2852-2853. 被引量:5
  • 3陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:775.
  • 4Robinson T, Smith A, Charmer KS. Reversible heart failure: the role of inflammatory activation [J]. Postgrad Med, 2011, 87:110 - 115.
  • 5Minguell JJ, Efices A. Mesenchymal stem cells and the treatment of cardiac diease [J]. Exp Biol Med, 2006, 231 (1) : 39 -49.
  • 6Butler J, Chomsky DB, Wilson JR. Pulmonary hypertension and exer- cise intolerance in patients with heart failure [ J ]. J Am Coll Cardiol, 1999, 34 (6): 1802-1806.
  • 7Gallelli L, Pelaia G, Fratto D, et al. Effects of budesonide on P38 MAPK activation, apoptosis and IL - 8 secretion, induced by TNF - al- pha and Hae- mophilus influenzae in human bronchial cell [J]. Int Immuno-pathol Pharmacol, 2010, 23 (2):471-479.
  • 8Abraham WT, Adams KF, Fonarow GC, et al. In - hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the acute decompensated heart failure national registry [ J ]. Am Coil Cardiol, 2005, 46 ( 1 ) : 57.
  • 9Livanis EG, Kostopoulou A, Theodorakis GN, et al. Neurocaidio- genic mechanisms of unexplained syncope in dilated cardiomyopathy [J]. Am J Cardio, 2007, 99 (4): 558-562.
  • 10Tenenbaum A, Fisman EZ, Motro M. Toward a redefinition of is- chemiccardiomyopathy :is it all indivisible entity [J]. J Am Coil Cardio 1,2002,40 ( 1 ) : 205 -206.

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部